This report provides exclusive insights into the COVID-19 impact on the Respiratory Drugs Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Respiratory Drugs Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Respiratory Drugs Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on respiratory drugs market provides an in-depth analysis of segments and sub-segments in global as well as regional respiratory drugs market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional respiratory drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global respiratory drugs market. According to the report the global respiratory drugs market is projected to grow at a CAGR of 7.1% over the forecast period of 2018-2024.
Increasing product innovation and approval in respiratory disease and disorders such as LABA/LAMA fixed-dose combinations in COPD, novel biologics in asthma and in cystic fibrosis (CF) are the key market trends anticipated to drive the global respiratory drugs market over the forecast period. Growing prevalence of respiratory diseases such as COPD, pulmonary hypertension, asthma, cystic fibers, allergic rhinitis and idiopathic pulmonary fibrosis owing to habits like overeating, smoking, and lack of exercise are the key factors responsible for the growth of global respiratory drugs market. Moreover, the increasing prevalence in respiratory disorders is further expected to drive the respiratory drug market over the forecast period globally.
The report on global respiratory drugs market covers disease segments. On the basis of disease the global respiratory drugs market is categorized into COPD, pulmonary hypertension, asthma, cystic fibrosis, allergic rhinitis, and idiopathic pulmonary fibrosis.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography is provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global respiratory drugs market such as FibroGen, Amgen, Dr. Reddy's Laboratories, Afferent Pharmaceuticals, Dainippon Sumitomo, Abbott, Horizon Pharma, Pfizer.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global respiratory drugs market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of respiratory drugs market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the respiratory drugs market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the respiratory drugs market to understand the present and future trends in this market and formulate their strategies accordingly.